Jupiter Wellness Inc

NASDAQ:JUPW   3:42:02 PM EDT
5.30
+0.75 (+16.48%)
Products, Regulatory

Jupiter Wellness Says Co's JW-100 Enters Clinical Trial For The Treatment Of Herpes

Published: 11/17/2020 13:46 GMT
(JUPW) - Jupiter Wellness’ Jw-100 Enters Clinical Trial for the Treatment of Herpes.
Jupiter Wellness- Initiated Exploratory Clinical Study in Treatment of Herpes Labialis (cold Sores) for Prescription Topical Cream Candidate Jw-100.
Jupiter Wellness Inc - Study Data to Be Used in Planned Ind Filing With U.S. FDA.